Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity. - Wikidata - wikimedia - TriplyDB

Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.

Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.

http://www.wikidata.org/entity/Q36094699

about

HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies.Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer.Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates.Natural infection as a blueprint for rational HIV vaccine design.Native-like Env trimers as a platform for HIV-1 vaccine design.Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers.Vaccine nanoparticles for protection against HIV infection.HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies.Dense Array of Spikes on HIV-1 Virion Particles.Evolution of B cell analysis and Env trimer redesign.Nanoparticles decorated with viral antigens are more immunogenic at low surface density.Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers.Neutralization tiers of HIV-1.Molecular basis of unusually high neutralization resistance in tier 3 HIV-1 strain 253-11.Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro.Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes

P2860

Q33753573-CC2617A6-09AB-491C-96FF-5B57AEC5278C Q36409575-4F74BE25-6F33-4399-8757-FF32717425DD Q37060947-08ACD5F8-FDC1-4C43-BBFD-881C63E1CEB1 Q37300461-DC14848A-EFD7-4588-9965-090D793AD0E4 Q37619134-5B52585B-A9B7-4078-B7D5-534ECC0DD9BA Q37633417-2099FD1E-4F60-4090-A353-53C3F3F4C7D2 Q37695592-A6F6294E-923B-47C5-829F-86BE9F0D0B22 Q38405327-71A0C9B5-497D-4167-AA20-393A15015999 Q38665463-150F22BC-E954-44E0-B1DE-5F750F559758 Q38817990-BC18380D-8CF0-46EA-8FD6-18E077905CDE Q38992740-40CCFA2F-5869-4431-BD20-017A2F43DB97 Q40393904-205EB17C-5C6D-4B44-959A-4CC4D6794003 Q40579418-AAED07BC-363E-4F88-8DCE-6BB0384D7B57 Q44169982-6E75AF98-205E-45FE-B8A4-90824736F069 Q47313525-51E806FD-EA81-48B9-8A9C-7EC6EB2C1A96 Q47562235-CFBE5F34-EACC-48FC-9DFD-ECE9C28A0C00 Q53695792-1531B69B-D3CF-403D-8F74-C7609F40F1F0 Q55374996-AE4EC8E4-4C76-40A7-A4EE-3550409A5FA1 Q57091049-6F9B34D5-7D3F-4739-A8FE-9CE8C8C89714 Q58589975-007AED17-E85A-461E-A4F7-6C2E8C198862

P2860

Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.

http://www.wikidata.org/entity/Q36094699

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Presenting native-like HIV-1 e ...... improves their immunogenicity.

@ast

Presenting native-like HIV-1 e ...... improves their immunogenicity.

@en

type

label

Presenting native-like HIV-1 e ...... improves their immunogenicity.

@ast

Presenting native-like HIV-1 e ...... improves their immunogenicity.

@en

prefLabel

Presenting native-like HIV-1 e ...... improves their immunogenicity.

@ast

Presenting native-like HIV-1 e ...... improves their immunogenicity.

@en

P1433

Q36094699-32420634-A73B-4F2D-95EA-A249D2697EDF

P1476

Q36094699-E27A4DF3-30AA-4E27-B811-3327BD3D5FAD

P2093

Q36094699-0018F091-A231-462D-8CB9-B68D84FFFAA9

Q36094699-040DC996-7AF0-43FB-B153-D79A79ACB929

Q36094699-0BE9B8C0-0719-4C4A-82CD-9C1C580C10C1

Q36094699-4031C88F-0616-41AC-AE0D-957C4D509888

Q36094699-8103BA85-F2E1-4D68-A0B9-3A2AA049503A

Q36094699-A245FB20-57C0-45E8-A408-721628E25E6C

Q36094699-A8BBB737-1998-46D9-8AE3-61FE130147C5

Q36094699-E12367B4-05E4-4E18-B09F-C90558DF9190

Q36094699-ED7815B5-CDE3-410E-BDA9-D44DDA602A49

P2860

Q36094699-0164A3F3-D5E9-4E32-93D4-022C1D6DE768

Q36094699-3333BE60-565C-4F77-8F90-243DE389641D

Q36094699-39E70E51-6055-4CBC-A635-598479BBC06E

Q36094699-3AD5EDF7-7EE6-43EA-8100-4A0E82A32FED

Q36094699-3DDF0CCE-4B4B-4705-B194-046013861210

Q36094699-4236D272-E968-421D-B02C-B7F1FB4BBF70

Q36094699-463B02C5-44FA-4CDB-BBCA-91E47BED26A1

Q36094699-4B07740F-DC37-4A13-B0C7-A1CDAF6A1A45

Q36094699-538D2C49-FA93-4FE3-94A2-78374427A8F0

Q36094699-652DD46B-0B22-4AF8-ACDB-5CA725932224

P2888

Q36094699-47B0A214-F647-4DB7-9F0F-DEA1E19FB8F6

P304

Q36094699-85E8F2C5-4C53-4866-B644-D7358C7C8347

P31

Q36094699-54A51D39-0C33-4A5F-BE34-887804A63E2A

P356

Q36094699-BA3110E6-316B-487C-BC26-99AF25458C62

P478

Q36094699-089761CA-4015-4E37-8FA7-30BBDA3064FC

P50

Q36094699-4CA1A430-7BBF-42C3-AE3E-530FD1EC0C2A

P577

Q36094699-95AD44A9-1B72-488A-97E2-726648084F8A

P5875

Q36094699-D3E9EC9E-5C77-41A6-A197-F0AE3703B813

P6179

Q36094699-BD3C0464-B689-4AC1-A8B2-B473A1C47902

P698

Q36094699-BE1F5389-573D-4D49-A6C0-1FE757EE289B

P921

Q36094699-75CE67F5-2B01-434E-9AC4-761201517E15

P932

Q36094699-66A1A660-1149-4BA1-B22B-6DC4530E1332

P356

S12977-015-0210-4

P1433

P1476

Presenting native-like HIV-1 e ...... improves their immunogenicity.

@en

P2093

Andrew B Ward

http://www.w3.org/2001/XMLSchema#string

Celia LaBranche

http://www.w3.org/2001/XMLSchema#string

Gabriel Ozorowski

http://www.w3.org/2001/XMLSchema#string

John P Moore

http://www.w3.org/2001/XMLSchema#string

Judith A Burger

http://www.w3.org/2001/XMLSchema#string

Kwinten Sliepen

http://www.w3.org/2001/XMLSchema#string

Melissa Stunnenberg

http://www.w3.org/2001/XMLSchema#string

Rogier W Sanders

http://www.w3.org/2001/XMLSchema#string

Thijs van Montfort

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies

HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies.

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.

Why HIV virions have low numbers of envelope spikes: implications for vaccine development.

Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.

P2888

s12977-015-0210-4

P304

82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12977-015-0210-4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

David C Montefiori

P577

2015-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282248544

http://www.w3.org/2001/XMLSchema#string

P6179

1004342486

http://www.w3.org/2001/XMLSchema#string

P698

26410741

http://www.w3.org/2001/XMLSchema#string

P921

P932

4583754

http://www.w3.org/2001/XMLSchema#string